WG Critical Care

WG Critical Care is a pharmaceutical company that specializes in the development and supply of injectable generic drugs for the hospital and critical care markets. Based in Paramus, New Jersey, the company provides a robust portfolio of essential medicines, including anti-infectives, cardiovascular agents, and anesthetics. In 2023, WG Critical Care was acquired by Gland Pharma, a major global player in the injectable manufacturing space, enhancing its supply chain and manufacturing capabilities. The company is recognized for its commitment to ensuring the availability of high-quality, cost-effective injectable therapies for healthcare providers. Its business model focuses on identifying market needs for generic injectables and navigating the regulatory pathway to bring these products to the U.S. market.